Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Ritvos

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Journal of the American Society of Nephrology : JASN|March 30, 2016
Inhibition of Activin Signaling Slows Progression of Polycystic Kidney DiseaseWouter N Leonhard, Steven J Kunnen, Anna J Plugge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2019
Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion InjuryJohanna Magga, Laura Vainio, Teemu Kilpiö, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2015
Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by InsulinP A Nidhina Haridas, Jarkko Soronen, Sanja Sädevirta, et al.
The Journal of Infectious Diseases|February 24, 2021
The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital MortalityEvgenia Synolaki, Vasileios Papadopoulos, Georgios Divolis, et al.
Frontiers in Immunology|December 6, 2024
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunityMilja Belik, Arttu Reinholm, Pekka Kolehmainen, et al.
Mbio|February 20, 2024
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infectionNatalie E Nieuwenhuizen, Geraldine Nouailles, Jayne S Sutherland, et al.
Communications Medicine|February 23, 2024
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infectionArttu Reinholm, Sari Maljanen, Pinja Jalkanen, et al.
Elife|August 6, 2016
Enhanced exercise and regenerative capacity in a mouse model that violates size constraints of oxidative muscle fibresSaleh Omairi, Antonios Matsakas, Hans Degens, et al.
Nature Communications|March 25, 2023
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariantsAnna R Mäkelä, Hasan Uğurlu, Liina Hannula, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 28, 2019
Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signallingKhalid Alyodawi, Wilbert P Vermeij, Saleh Omairi, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of the American Society of Nephrology : JASN|March 30, 2016
Inhibition of Activin Signaling Slows Progression of Polycystic Kidney DiseaseWouter N Leonhard, Steven J Kunnen, Anna J Plugge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2019
Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion InjuryJohanna Magga, Laura Vainio, Teemu Kilpiö, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2015
Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by InsulinP A Nidhina Haridas, Jarkko Soronen, Sanja Sädevirta, et al.
The Journal of Infectious Diseases|February 24, 2021
The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital MortalityEvgenia Synolaki, Vasileios Papadopoulos, Georgios Divolis, et al.
Frontiers in Immunology|December 6, 2024
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunityMilja Belik, Arttu Reinholm, Pekka Kolehmainen, et al.
Mbio|February 20, 2024
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infectionNatalie E Nieuwenhuizen, Geraldine Nouailles, Jayne S Sutherland, et al.
Communications Medicine|February 23, 2024
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infectionArttu Reinholm, Sari Maljanen, Pinja Jalkanen, et al.
Elife|August 6, 2016
Enhanced exercise and regenerative capacity in a mouse model that violates size constraints of oxidative muscle fibresSaleh Omairi, Antonios Matsakas, Hans Degens, et al.
Nature Communications|March 25, 2023
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariantsAnna R Mäkelä, Hasan Uğurlu, Liina Hannula, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 28, 2019
Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signallingKhalid Alyodawi, Wilbert P Vermeij, Saleh Omairi, et al.
Pageof 9